Evidence of cyclic changes in the metabolism of abdominal aortic aneurysms during growth phases: 18F-FDG PET sequential observational study

Journal of Nuclear Medicine

Volumn 56, Issue 7, 2015, Pages 1030-1035

  Morel, Olivier ^a,b,c   Mandry, Damien ^a,b,c   Micard, Emilien ^b,c   Kauffmann, Claude ^d   Lamiral, Zohra ^b   Verger, Antoine ^a,b,c   Chevalier Mathias, Elodie ^a,b   Mathias, Julien ^a   Karcher, Gilles ^a,b,c   Meneroux, Benoit ^a   Rossignol, Patrick ^b,c   Marie, Pierre Yves ^a,b,c  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

18F FDG; Abdominal aortic aneurysms; CT angiography; Maximal diameter; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM; RADIOPHARMACEUTICAL AGENT;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTERY DIAMETER; ARTICLE; ASYMPTOMATIC DISEASE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; FEMALE; HUMAN; MALE; METABOLISM; OBSERVATIONAL STUDY; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; ANGIOGRAPHY; ATHEROSCLEROSIS; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MIDDLE AGED; MULTIMODAL IMAGING; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SCINTISCANNING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84936742508     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.146415     Document Type: Article

References (27)

1. Guirguis-Blake JM, Beil TL, Senger CA, Whitlock EP. Ultrasonography screening for abdominal aortic aneurysms: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:321-329.
2. Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance: UK Small Aneurysm Trial Participants. Ann Surg. 1999;230:289-296.
3. Powell JT, Gotensparre SM, Sweeting MJ, Brown LC, Fowkes FG, Thompson SG. Rupture rates of small abdominal aortic aneurysms: A systematic review of the literature. Eur J Vasc Endovasc Surg. 2011;41:2-10.
4. United Kingdom Small Aneurysm Trial Participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1445-1452.
5. Thompson AR, Cooper JA, Ashton HA, Hafez H. Growth rates of small abdominal aortic aneurysms correlate with clinical events. Br J Surg. 2010;97:37-44.
6. Reeps C, Essler M, Pelisek J, Seidl S, Eckstein HH, Krause BJ. Increased 18Ffluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/ computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg. 2008;48:417-423.
7. Reeps C, Bundschuh RA, Pellisek J, et al. Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms: correlation with histology and role of partial volume correction. Int J Cardiovasc Imaging. 2013;29:505-512.
8. Courtois A, Nusgens BV, Hustinx R, et al. 18F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. J Nucl Med. 2013;54: 1740-1747.
9. Reeps C, Gee MW, Maier A, et al. Glucose metabolism in the vessel wall correlates with mechanical instability and inflammatory changes in a patient with a growing aneurysm of the abdominal aorta. Circ Cardiovasc Imaging. 2009; 2:507-509.
10. Choke E, Cockerill G, Wilson WR, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg. 2005;30:227-244.
11. Sakalihasan N, Van Damme H, Gomez P, et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg. 2002;23:431-436.
12. Palombo D, Morbelli S, Spinella G, et al. A positron emission tomography/ computed tomography (PET/CT) evaluation of asymptomatic abdominal aortic aneurysms: another point of view. Ann Vasc Surg. 2012;26:491-499.
13. Marini C, Morbelli S, Armonino R, et al. Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study. Eur J Nucl Med Mol Imaging. 2012;39:91-101.
14. Kotze CW, Groves AM, Menezes LJ, et al. What is the relationship between 18FFDG aortic aneurysm uptake on PET/CT and future growth rate? Eur J Nucl Med Mol Imaging. 2011;38:1493-1499.
15. Mandry D, Tatopoulos A, Chevalier-Mathias E, et al. 18F-fluorodeoxyglucose positron emission tomography combined with whole-body computed tomographic angiography in critically ill patients with suspected severe sepsis with no definite diagnosis. Eur J Nucl Med Mol Imaging. 2014;41:1924-1930.
16. Grandpierre S, Desandes E, Meneroux B, et al. Arterial foci of F-18 fluorodeoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: A case-control pilot study. Clin Nucl Med. 2011;36:85-90.
17. Rudd JH, Myers KS, Bansilal S, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871-878.
18. Cayne NS, Veith FJ, Lipsitz EC, et al. Variability of maximal aortic aneurysm diameter measurements on CT scan: significance and methods to minimize. J Vasc Surg. 2004;39:811-815.
19. Kauffmann C, Tang A, Therasse E, et al. Measurements and detection of abdominal aortic aneurysm growth: accuracy and reproducibility of a segmentation software. Eur J Radiol. 2012;81:1688-1694.
20. Tegler G, Ericson K, Sörensen J, Björck M, Wanhainen A. Inflammation in the walls of asymptomatic abdominal aortic aneurysms is not associated with increased metabolic activity detectable by 18-fluorodeoxglucose positron-emission tomography. J Vasc Surg. 2012;56:802-807.
21. Brammen L, Palumbo B, Lupattelli G, Sinzinger H. Is 18F-FDG PET really a promising marker for clinically relevant atherosclerosis? Hell J Nucl Med. 2014;17:62-63.
22. Folco EJ, Sheikine Y, Rocha VZ, et al. Hypoxia but not inflammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol. 2011;58:603-614.
23. Michel JB, Martin-Ventura JL, Egido J, et al. FAD EU consortium: novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res. 2011;90:18-27.
24. Ben-Haim S, Kupzov E, Tamir A, Frenkel A, Israel O. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies. J Nucl Cardiol. 2006;13:791-800.
25. Menezes LJ, Kayani I, Ben-Haim S, Hutton B, Ell PJ, Groves AM. What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque. Atherosclerosis. 2010;211:136-140.
26. Kurvers H, Veith FJ, Lipsitz EC, et al. Discontinuous, staccato growth of abdominal aortic aneurysms. J Am Coll Surg. 2004;199:709-715.
27. Vega de Céniga M, Gómez R, Estallo L, de la Fuente N, Viviens B, Barba A. Analysis of expansion patterns in 4-4.9 cm abdominal aortic aneurysms. Ann Vasc Surg. 2008;22:37-44.